Home > Cardiology > The scope of remote healthcare in hypertension and hyperlipidaemia

The scope of remote healthcare in hypertension and hyperlipidaemia

Expert
Dr Alexander Blood, Brigham and Women’s Hospital, Massachusetts
Conference
AHA 2021
A remote, algorithm-driven programme with over 10,000 enrolled participants was able to reduce hypertension and LDL cholesterol in patients with a high risk for cardiovascular events. The programme may reduce the need for in-person visitations. Moreover, the remote programme could provide equitable care across underserved populations. Medicom spoke with Dr Alexander Blood (Brigham and Women’s Hospital, MA, USA), the first author of the current study. The results of the remote healthcare programme were presented as a late-breaking abstract during the 2021 virtual meeting of the American Heart Association Scientific Sessions, 13–15 November [1]. [caption id="attachment_26283" align="alignright" width="223"]


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on